Product Information
TIADYLT ER 300 MG CAPSULE is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.2567 per EA under NDC 68382074816. Its NADAC has been published 335 times since Mar 25, 2020.
FDA first approved this application on Aug 11, 2017. Its Orange Book therapeutic-equivalence code is AB4 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
300 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
68382074816
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
DILTIAZEM HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA206641FDA Approved
8/11/2017
TE Code
AB4
On Market Since
11/8/2017
Pharmacological Classes
Price Statistics
The NADAC for TIADYLT ER 300 MG CAPSULE has been published 335 times since Mar 25, 2020, and over the history we have for it it has declined 53.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2567 per EA |
|---|---|
| All-time high | $0.7662 (Jul 14, 2021) |
| All-time low | $0.1727 (Jan 21, 2026) |
| 52-week high | $0.5394 |
| 52-week low | $0.1727 |
| Median price | $0.5578 |
| Average price | $0.5355 |
| Largest weekly change | +62.9% (May 17, 2023) |
| Weeks tracked | 335 |
| Tracking since | Mar 25, 2020 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TIADYLT ER 300 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TIADYLT ER 300 MG CAPSULE, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.2567 per EA (NDC 68382074816), effective Aug 19, 2026.
How has the price of TIADYLT ER 300 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TIADYLT ER 300 MG CAPSULE has declined 53.2%. It has been tracked across 335 weekly CMS publications since Mar 25, 2020.
What are the highest and lowest recorded NADAC prices for TIADYLT ER 300 MG CAPSULE?
Since Mar 25, 2020, the NADAC for TIADYLT ER 300 MG CAPSULE has ranged from a low of $0.1727 (Jan 21, 2026) to a high of $0.7662 (Jul 14, 2021), with a median of $0.5578 per EA.
Are there cheaper alternatives to TIADYLT ER 300 MG CAPSULE?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TIADYLT ER 300 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures TIADYLT ER 300 MG CAPSULE?
TIADYLT ER 300 MG CAPSULE (NDC 68382074816) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.